Kuros Biosciences Ltd.

Report Publication Announcement • Jul 23, 2009

News Details

Corporate | 23 July 2009 07:00

Cytos Biotechnology Ltd Second Quarter Report 2009

Cytos Biotechnology AG / Quarter Results

Release of a Corporate News, transmitted by DGAP - a company of EquityStory
AG.
The issuer / publisher is solely responsible for the content of this announcement.

---

Cytos Biotechnology Ltd Second Quarter Report 2009 as of June 30, 2009

Summary of important events in Q2 2009

• Cytos Biotechnology reported biochemical findings from a phase IIa
  study with the hypertension vaccine CYT006-AngQb

• Initiation of a combined phase I/IIa study with a novel
  anti-interleukin-1 beta vaccine in patients with type II diabetes
  mellitus

• Initiation of a phase IIa study with the immunotherapy CYT003-QbG10 in
  patients with allergic asthma bronchiale

• Upcoming event:

Presentation of Cytos Biotechnology at the World Vaccine Congress, October
5-8, 2009 in Lyon, France

• Financial summary

in CHF million YTD* 09 YTD* 08 Q2 09 Q2 08

Revenue 6.6 5.5 6.3 5.2
Net operating costs (22.4) (20.5) (11.4) (10.1)
Net loss (18.0) (15.7) (6.2) (5.4)

                                  06/30/09  12/31/08

Cash, cash equivalents, 77.9 98.0
financial assets
and trade receivables

Full-time employees (number) 117 132

* YTD = year to date January 1 - June 30

The complete Second Quarter Report can be downloaded on Cytos
Biotechnology's website under the following link:

http://www.cytos.com/userfiles/file/Cytos_Q2_2009_E.pdf

Jakob Schlapbach, MBA
Chief Financial Officer
Cytos Biotechnology Ltd
Phone: +41 44 733 46 46
Fax: +41 44 733 47 02
e-Mail: jakob.schlapbach@cytos.com
Website: www.cytos.com

23.07.2009 Financial News transmitted by DGAP

Language: English
Issuer: Cytos Biotechnology AG
Wagistr. 25
8952 Schlieren
Schweiz
Phone: +41 44 733 4747
Fax: +41 44 733 4740
E-mail: info@cytos.com
Internet: www.cytos.com
ISIN: CH0011025217, CH0029060735
WKN: -
Listed: Freiverkehr in Berlin, München, Stuttgart; Open Market in
Frankfurt; Foreign Exchange(s) SWX

End of News DGAP News-Service

---